Jump To: What Is Molybdenum-99 Used For? [...]
A test engineer works in SHINE's manufacturing [...]
SHINE Medical Technologies LLC today announced the completion of its new corporate headquarters. The company now has three facilities on its campus on U.S. Highway 51 across from the Southern Wisconsin Regional Airport.
SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. Koch Disruptive Technologies (KDT) led the round, which also included participation by Fidelity Management & Research Company, Baillie Gifford and other new and current investors.
SHINE Medical Technologies LLC today announced that it has entered a multi-year contract with the University of Missouri Research Reactor, or MURR®, for irradiation of ytterbium-176.
SHINE Medical Technologies LLC today announced that they have entered into a distribution agreement enabling EDH to act as a SHINE-authorized distributor for selected countries
SHINE Medical Technologies LLC today announced that it has selected the municipality of Veendam in the province of Groningen, the Netherlands, as the location of its European medical isotope production facility. The decision is the culmination of a year-long search process that included the review of more than 50 proposals from sites across Europe.
Humanity has gone as far as it can go on fossil fuels, and likely quite a bit farther on top of that. Fossil fuels—natural gas, coal, and oil—have fed our civilization’s explosive growth since the Industrial Revolution.